The tumor suppressive activity of plakoglobin may be via nuclear translocation to antogonize β-catenin binding to TCF/LEF proteins in keratinocytes [36], supporting our model that plakoglobin competes with SOX4-β-catenin interactions in the nucleus. Here, SOX4 is linked to neoplasm.